About: S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

clinical trial

Attributes	Values
rdf:type	Item
description	clinical trial (en) ensayu clínicu (ast) klinisch onderzoek (nl) клінічне випробування (uk)
rdfs:label	S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma (en) S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma (nl)
skos:prefLabel	S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma (en) S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma (nl)
name	S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma (en) S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma (nl)
title	wds:Q66037438-318E7A6C-A2EE-4598-B187-B2CA77BDA562
title	Phase III Trial of High Dose Interferon Alfa 2-b Versus Cisplatin, Vinblastine, DTIC Plus IL-2 and Interferon in Patients With High Risk Melanoma (en)
end time	wds:Q66037438-5B5CF215-D611-4EEA-B158-14761A354F31
end time	2012-07-01 00:00:00Z (xsd:dateTime)
instance of	wds:Q66037438-B064A25A-6556-47B6-9BE2-6F729C99BCCA
instance of	clinical trial
start time	wds:Q66037438-04A250E4-67DA-4820-99B4-A44475DDB558
start time	2000-08-01 00:00:00Z (xsd:dateTime)
country	wds:Q66037438-23177984-F5D8-40D6-BAD7-B880BD9CD4D5 wds:Q66037438-25FC7776-D5BE-463C-BF26-50801D37BB7F
country	Australia United States of America
main subject	wds:Q66037438-9C0632AD-FBE6-49B2-8E27-64B335D4EAE1
main subject	Stage III melanoma incidence and impact of transitioning to the 8th AJCC staging system: a US population-based study
research site	wds:Q66037438-025FAB81-4D13-4B73-A0B7-B405258B39D1 wds:Q66037438-094CD444-3259-48A6-9BC4-3A9209829AAA wds:Q66037438-0D5398C8-3B0C-476B-B2DA-F040959CE4D9 wds:Q66037438-0E842FCC-4B59-4631-A31A-8EFD93489DBF wds:Q66037438-0F320C9C-C1C3-4AB4-A29B-F5E1717F94E8 wds:Q66037438-27793CE6-4126-4754-8709-BEF48089FB28 wds:Q66037438-377341D9-111E-4E79-A8C9-BDACFA7D8D6D wds:Q66037438-43F9FD60-067F-437F-AAE3-69660A2CCE1F wds:Q66037438-442EE69A-7997-4709-B255-F485C6A28806 wds:Q66037438-477164A5-E5CF-4442-86D5-23250D1700C5 wds:Q66037438-4B7909AD-2037-4E00-B931-EBCA75664F80 wds:Q66037438-500906E1-8BA6-462E-90E2-8777495B15A7 wds:Q66037438-52590EF0-5512-44E5-B126-2591BFA99776 wds:Q66037438-575639D3-68F2-4A99-A906-6B3E3BE5D3D4 wds:Q66037438-5FADDC75-DA00-4840-9942-C98769998C76 wds:Q66037438-6AEE858D-8271-4DC2-8FFC-F8497EDB6DCD wds:Q66037438-6BF9E81A-F08A-4304-942E-A7D77CF3DED7 wds:Q66037438-6D8BD04B-C034-4210-8D19-60070CC2417A wds:Q66037438-75C60B49-F7B5-4151-B80E-B31FC95A084B wds:Q66037438-BCEC3065-3F3F-4C45-9115-BC83BC0A7026 wds:Q66037438-BFD7E6CC-EBA5-472C-B7D2-5487EF7F2B26 wds:Q66037438-C279ED08-08B5-4986-AA29-DBA255B52F82 wds:Q66037438-C9D5A02E-5120-488B-984D-50FB1D178883 wds:Q66037438-CCC2CA45-36D6-4C34-90A4-0FEA3EDE14B7 wds:Q66037438-DFD2B153-117A-431F-A2D6-DA4EC43EBB0D wds:Q66037438-E04D2E36-F916-49C9-815D-F9C23C431F3C wds:Q66037438-F507D70A-A14A-4898-BC8B-57D92AB9528A
research site	University of Texas at Houston Police Department Vanderbilt University Fred Hutchinson Cancer Research Center Cook Children's Medical Center Beth Israel Deaconess Medical Center Swedish Medical Center Wilford Hall Medical Center Hurley Medical Center Munson Medical Center Phoenix Children's Hospital Grady Memorial Hospital Barbara Ann Karmanos Cancer Institute Children's National Hospital University of Michigan Princess Margaret Hospital for Children UNM Los Lunas MetroHealth Medical Center Park Nicollet Methodist Hospital Hematology Oncology Associates of Central New York Metro-Minnesota Community Oncology Research Consortium Michigan Cancer Research Consortium Elkhart General Hospital Iowa Methodist Medical Center Mercy Medical Center West Michigan Cancer Center Hackley Hospital Emergency heliport Harrington Cancer Center
research intervention	wds:Q66037438-46C0CB4D-20E5-40D3-9ED9-FEBEA205695F wds:Q66037438-D9BD4629-B735-427F-8077-F9828C91A75B
research intervention	cisplatin interferon-alpha
minimum age	wds:Q66037438-F97D1A31-CECF-4F13-9453-4F3B252DF728
minimum age	18 (xsd:decimal)
medical condition	wds:Q66037438-556D53ED-F2E7-4EBD-B6A0-8F666FBA4CEB
medical condition	melanoma
number of participants	wds:Q66037438-BA70EFF3-C35C-476A-91A3-56330168055F
number of participants	432 (xsd:decimal)
study type	wds:Q66037438-CCE01071-F022-4EF1-AFB5-E6646D9BDB20
study type	interventional study
ClinicalTrials.gov ID	wds:Q66037438-9E1CFA31-6191-4366-A9D6-224A188A0804
ClinicalTrials.gov ID	NCT00006237
clinical trial phase	wds:Q66037438-B7F5E06C-27F0-43FD-926C-E0C183FF1DE1
clinical trial phase	phase III clinical trial
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q66037438

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software